DR. RIFAT PAMUKCU, M.D.
Osteopathic Medicine at Pump House, North Wales, PA
License number
Pennsylvania MD055010L
Category
Osteopathic Medicine
Type
Gastroenterology
Address
Address
2 Pump House, North Wales, PA 19477
Phone
(215) 628-0938
Personal information
See more information about RIFAT PAMUKCU at radaris.comName
Address
Phone
2 Pump House, Spring House, PA 19477
216 Pinecrest Ln, Lansdale, PA 19446
2 Pump House, Spring House, PA 19477
2 Pump House, Ambler, PA 19002
Organization information
See more information about RIFAT PAMUKCU at bizstanding.comRifat Pamukcu MD
2 Pump House, Spring House, PA 19477
Industry:
Internist
Phone:
(215) 628-0938 (Phone)
Rifat Pamukcu
Professional information
Method Of Treating A Patient Having Precancerous Lesions With Phenyl Quinazolinone Derivatives
US Patent:
6562830, May 13, 2003
Filed:
Nov 9, 1999
Appl. No.:
09/436806
Inventors:
Rifat Pamukcu - Spring House PA
Gary A. Piazza - Highlands Ranch CO
Gary A. Piazza - Highlands Ranch CO
Assignee:
Cell Pathways, Inc. - Horsham PA
International Classification:
A61K 31505
US Classification:
514259, 51425214, 5142348
Abstract:
Derivatives of 2-phenyl quinazolinones are useful for the treatment of patients having precancerous lesions. These compounds are also useful to inhibit growth of neoplastic cells.
Method For Treating A Patient Having Precancerous Lesion With 4-Phenylphthalazine Derivatives
US Patent:
6207666, Mar 27, 2001
Filed:
Apr 23, 1998
Appl. No.:
9/065662
Inventors:
Gary Piazza - Highlands Ranch CO
Rifat Pamukcu - Spring House PA
Rifat Pamukcu - Spring House PA
Assignee:
Cell Pathways, Inc. - Horsham PA
International Classification:
A61K31/495;31/50
US Classification:
514248
Abstract:
Derivatives of 4-phenylphthalazine are useful for the treatment of patients having precancerous lesions. These compounds are also useful to inhibit the growth of neoplastic cells.
Method For Treating Neoplasia With Amino Or Pyridylamino Cyclobutene Derivatives
US Patent:
6211220, Apr 3, 2001
Filed:
Nov 23, 1998
Appl. No.:
9/199082
Inventors:
Rifat Pamukcu - Spring House PA
Gary A. Piazza - Doylestown PA
Gary A. Piazza - Doylestown PA
Assignee:
Cell Pathways, Inc. - Horsham PA
International Classification:
A61K 31415, A61K 3150, A61K 31495, A61K 31505, A61K 3144, A61K 3142, A61K 31405, A61K 3138
US Classification:
514399
Abstract:
A method for inhibiting neoplasia, particularly cancerous and precancerous lesions by exposing the affected cells to amino or pyridylamino cyclobutane derivatives.
Indenyl Hydroxamic Acids, (Hydroxy) Ureas And Urethanes For Treating Patients With Precancerous Lesions
US Patent:
6300346, Oct 9, 2001
Filed:
Mar 7, 2000
Appl. No.:
9/520667
Inventors:
Gerhard Sperl - Stockton CA
Paul Gross - Stockton CA
Klaus Brendel - Tucson AZ
Rifat Pamukcu - Spring House PA
Gary A. Piazza - Highlands Ranch CO
Paul Gross - Stockton CA
Klaus Brendel - Tucson AZ
Rifat Pamukcu - Spring House PA
Gary A. Piazza - Highlands Ranch CO
Assignee:
Cell Pathways, Inc. - Horsham PA
International Classification:
A61K 3144, A61K 3138, A61K 3117
US Classification:
514332
Abstract:
Indenyl hydroxamic acids, (hydroxy) ureas and urethanes are useful in the treatment of precancerous lesions and neoplasms.
Method For Identifying Compounds For Inhibition Of Cancerous Lesions
US Patent:
5858694, Jan 12, 1999
Filed:
May 30, 1997
Appl. No.:
8/866027
Inventors:
Gary A. Piazza - Doylestown PA
Rifat Pamukcu - Spring House PA
W. Joseph Thompson - Mobile AL
Rifat Pamukcu - Spring House PA
W. Joseph Thompson - Mobile AL
Assignee:
Cell Pathways, Inc. - Horsham PA
International Classification:
C12Q 144
US Classification:
435 19
Abstract:
This invention provides a method to identify compounds potentially useful for the treatment of neoplasia in mammals. The phosphodiesterase inhibitory activity of a compound is determined along with COX inhibitory activity. Growth inhibitory and apoptosis inducing effects on cultured tumor cells are also determined. Compounds that exhibit phosphodiesterase inhibiton, growth inhibition and apoptosis induction, but not substantial prostaglandin inhibitory activity, are desirable for the treatment of neoplasia.
Method For Inhibiting Neoplastic Cells And Related Conditions By Exposure To 2,8-Disubstituted Quinazoline Derivatives
US Patent:
6187779, Feb 13, 2001
Filed:
Nov 20, 1998
Appl. No.:
9/197311
Inventors:
Rifat Pamukcu - Spring House PA
Gary A. Piazza - Doylestown PA
Gary A. Piazza - Doylestown PA
Assignee:
Cell Pathways, Inc. - Horsham PA
International Classification:
A01N 4354, A61K 31505
US Classification:
514259
Abstract:
A method for inhibiting neoplastic cells and related conditions by exposing them to 2,8 disubstituted quinazolinone compounds.
Method For Treating A Patient With Neoplasia By Treatment With A Paclitaxel Derivative
US Patent:
6235776, May 22, 2001
Filed:
Nov 12, 1998
Appl. No.:
9/190637
Inventors:
Rifat Pamukcu - Spring House PA
Kerstin B. Menander - Meadowbrook PA
Kerstin B. Menander - Meadowbrook PA
Assignee:
Cell Pathways, Inc. - Horsham PA
International Classification:
A61K 31235, A01N 3710
US Classification:
514468
Abstract:
This invention provides a method for treating a patient with neoplasia by an adjuvant therapy that includes treatment with a paclitaxel derivative.
Substituted Condensation Products Of N-Benzyl-3-Indenyl Acetamides With Heterocyclic Aldehydes
US Patent:
5948779, Sep 7, 1999
Filed:
Dec 12, 1997
Appl. No.:
8/989353
Inventors:
Gerhard J. Sperl - Stockton CA
Paul Gross - Stockton CA
Klaus Brendel - Tuscon AZ
Gary A. Piazza - Doylestown PA
Rifat Pamukcu - Spring House PA
Paul Gross - Stockton CA
Klaus Brendel - Tuscon AZ
Gary A. Piazza - Doylestown PA
Rifat Pamukcu - Spring House PA
Assignee:
Cell Pathways, Inc. - Horsham PA
International Classification:
C07D21324, C07D21512, A61K 3134, A61K 3138
US Classification:
514241
Abstract:
Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes are useful for inducing or promoting apotosis and for arresting uncontrolled neoplastic cell proliferation, and are specifically useful in the arresting and treatment of neoplasias, including precancerous and cancerous lesions.
Substituted Condensation Products Of N-Benzyl-3-Idenylacetamides With Heterocyclic Aldehydes For Neoplasia
US Patent:
6166053, Dec 26, 2000
Filed:
Jan 24, 2000
Appl. No.:
9/490269
Inventors:
Gerhard J. Sperl - North Wales PA
Paul Gross - Stockton CA
Klaus Brendel - Tuscon AZ
Gary A. Piazza - Doylestown PA
Rifat Pamukcu - Spring House PA
Paul Gross - Stockton CA
Klaus Brendel - Tuscon AZ
Gary A. Piazza - Doylestown PA
Rifat Pamukcu - Spring House PA
Assignee:
Cell Pathways, Inc. - Horsham PA
International Classification:
A61K 314409, C07D21356
US Classification:
514357
Abstract:
Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes are useful for inducing or promoting apotosis and for arresting uncontrolled neoplastic cell proliferation, and are specifically useful in the arresting and treatment of neoplasias, including precancerous and cancerous lesions.
Substituted Methoxy Benzylidene Indenyl-Acetic And Propionic Acids For Treating Patients With Precancerous Lesions
US Patent:
5998477, Dec 7, 1999
Filed:
Jun 3, 1997
Appl. No.:
8/868181
Inventors:
Gerhard Sperl - Stockton CA
Paul Gross - Stockton CA
Klaus Brendel - Tucson AZ
Gary Piazza - Doylestown PA
Rifat Pamukcu - Spring House PA
Paul Gross - Stockton CA
Klaus Brendel - Tucson AZ
Gary Piazza - Doylestown PA
Rifat Pamukcu - Spring House PA
Assignee:
Cell Pathways Inc. - Horsham PA
International Classification:
A61K 3119, A61K 31215, A61K 31235
US Classification:
514569
Abstract:
Substituted methoxy benzylidene indenyl compounds are useful in the treatment of precancerous lesions and neoplasms.